The ectoenzymes CD39 and CD73 degrade extracellular ATP to adenosine. ATP is released by stressed or damaged cells and provides pro-inflammatory signals to immune cells through P2 
Introduction
Extracellular adenine nucleotides are important regulators of immune responses [1, 2] . ATP is released by stressed, damaged or dying cells and acts as a damage-associated molecular pattern (DAMP) provoking and enhancing local immune responses. Immune cells use ionotropic P2X receptors and metabotropic P2Y receptors to sense extracellular ATP (eATP) [1] . Through stimulation of P2Y receptors, eATP acts as a chemotactic factor for granulocytes, macrophages a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
and dendritic cells [3] [4] [5] . Stimulation of P2X7 on macrophages activates the NLRP3 inflammasome [6] . P2X receptors are also expressed on T-cell subsets, and eATP stimulation of P2X7 can modulate the function of T h17 cells, T r1 cells and T reg cells [2, [7] [8] [9] [10] and cause apoptosis of T cells [10, 11] . In contrast to eATP, extracellular adenosine is mainly considered as an inhibitory signal of the immune system [12] . By engaging P1 receptors, extracellular adenosine dampens the function of a variety of immune cells, including antigen-presenting cells and T cells, thus dampening the immune response [1, 2, [13] [14] [15] [16] [17] [18] [19] [20] .
CD39 (ectonucleoside triphosphate diphosphohydrolase 1, ENTPD1) is a major hydrolase for eATP. CD39 hydrolyses eATP and eADP to eAMP, which is further degraded to adenosine by CD73 (ecto-5' nucleotidase, NT5E) [12, 21] . By degrading eATP, CD39 limits inflammatory processes and, in cooperation with CD73, generates extracellular adenosine, which further dampens immune responses. CD39 and CD73 are expressed on hematopoietic and non-hematopoietic cells, and the expression of these ectoenzymes allows cells to shape the quality of immune responses. The immune modulatory function of CD39 and CD73 has been extensively studied in T reg cells [22] [23] [24] . Mouse T reg cells express CD39 and CD73 and generate adenosine to suppress immune responses [22] . CD39 is also expressed by subsets of human T reg cells, but these cells mostly fail to co-express CD73 [25, 26] . For conventional T cells (non-T reg cells), CD39 and CD73 have been proposed as markers of activation and exhaustion [27] [28] [29] [30] . It is also possible that, similar to T reg cells, conventional T-cell populations use CD39 to reduce eATP in their environment. This would dampen local inflammation but could also directly interfere with eATPdependent activation and differentiation processes of these cells. Interestingly, T cells from mucosal tissues express relatively high levels of CD39 and CD73 [31] . In the gut, high expression levels of CD39 and CD73 could protect T cells and other intestinal cells from adverse effects of eATP derived from commensal bacteria of the intestinal lumen [23, 31, 32] .
In this study, we have analyzed the expression and function of CD39 on conventional mouse and human CD4 + [34] . Bacterial inocula were controlled by plating serial dilutions on tryptic soy broth (TSB) agar. For determination of bacterial burdens, organs were homogenized in H 2 O, serial dilutions of homogenates were plated on TSB agar and colonies were counted after 24h incubation at 37˚C.
Materials and methods

Mice and Listeria monocytogenes infection
Isolation and stimulation of cells
Cells from mouse spleens were obtained by mashing the organs through cell sieves into PBS, followed by erythrocyte lysis with lysing buffer (155mM NH 4 Cl, 10mM KHCO 3 , 100μM EDTA, pH 7.2). Cells were incubated in RPMI 1640 medium supplemented with 5% FCS, L-glutamine, pyruvate, gentamicin and 2-mercaptoethanol. For the induction of cytokines in T cells, spleen cells were stimulated for 4h at 37˚C with 10 -6 M ovalbumin peptide (OVA 257-264 ; SIINFEKL) and 10 −5 M listeriolysin O peptide (LLO 189-201 ; WNEKYAQAYPNVS) (both JPT, Berlin, Germany) or phorbol 12-myristate 13-acetate (PMA, 50ng/ml, Sigma Aldrich, St. Louis, MO) and ionomycin (1μM, Sigma Aldrich). Brefeldin A (10μg/ml, Sigma Aldrich) was added for the last 3.5h of culture to prevent protein secretion. Cytokine expression was determined by intracellular staining and flow cytometry. For the induction of cytokine secretion, spleen cells were incubated for 16h at 37˚C with Lm. Supernatants were collected and analyzed for TNF-α and IL-1β content by ELISA (R&D Systems, Minneapolis, MN). Unless stated otherwise, peripheral blood was obtained from healthy volunteers. Blood and synovial fluid (SF) of patients with juvenile idiopathic arthritis (JIA) were obtained from patients visiting the University Medical Center Hamburg-Eppendorf, the Altona Children's Hospital or the Medical Center Bad Bramstedt. Joints of patients were punctured for diagnostic or therapeutic reasons. Collection procedures were approved by the local ethics committee (Ethik-Kommission der Ä rztekammer Hamburg. PV5139 for samples from healthy donors and PV3746 for samples from JIA patients). Human peripheral blood mononuclear cells (PBMCs) were isolated from venous blood by Biocoll gradient centrifugation (Biochrom, Berlin, Germany). Cells were cultured in human RPMI 1640 medium supplemented with 10% FCS, L-glutamine, penicillin, streptomycin. For activation of T cells, PBMCs (1×10 6 /ml) were cultured with 0.5μg/ml anti-CD3 mAb (clone OKT3, BioLegend, San Diego, CA). Flow cytometric analysis of cells was performed on the indicated days.
Flow cytometric analysis
For surface staining of human cells, 100μl of whole blood, 0.5-1×10 6 PBMCs or 1×10 5 SF cells were incubated with hIgG (Jackson ImmunoResearch Inc., West Grove, PA) to minimize unspecific antibody binding. Fluorochrome-conjugated mAbs were added and cells were incubated for 30min. In case of whole blood staining, this step was followed by erythrocyte lysis (Lysing Solution, BD Biosciences, San Jose, CA). For exclusion of dead cells a fixable dead cell stain (LIVE/DEAD Cell Viability Assay, Live Technologies, Carlsbad, CA) was added. For intracellular staining of Foxp3, PBMCs were surface stained, washed with PBS and then fixed and permeabilized using Foxp3-Transcription Factor Staining Buffer (eBioscience). To minimize unspecific anti-Foxp3 mAb binding, cells were incubated in permeabilization buffer with 1:100 mouse serum for 10min before the addition of anti-Foxp3 mAb. Cells were incubated for 30min at 4˚C and then washed with permeabilization buffer. Mouse cells were incubated with 10μg/ml 2.4G2 (anti-FcγRII/III; BioXCell, West Lebanon, NH) and 1:100 rat serum in PBS to minimize unspecific antibody binding. Staining was performed on ice with fluorochrome-conjugated mAbs (see below). For detection of intracellular proteins, cells were surface stained and then incubated with a fixable dead cell stain (Pacific Orange succinimidyl ester; Life Technologies) to exclude dead cells from analysis. Cells were washed with PBS and fixed for 20min with PBS, 2% paraformaldehyde at room temperature. Thereafter, cells were washed with PBS, 0.2% BSA, permeabilized with PBS, 0.1% BSA, 0.3% saponin (Sigma, Aldrich), and incubated in this buffer with 1:100 rat serum. After 5min, fluorochromeconjugated antibodies were added. After further 20min on ice, cells were washed with PBS.
Samples were analyzed with a FACS Canto II or LSRFortessa flow cytometer (BD Biosciences). Results were evaluated using the FlowJo software (Treestar, Ashland, OR, USA).
Fluorochrome-conjugated anti-human mAbs: anti-CD3 (clones UCHT1 or OKT3), anti-CD4 (RPA-T4), anti-CD8α (RPA-T8 or HIT8a), anti-CD25 (2A3), anti-CD39 (A1), anti-CD45RA (HI100), anti-CD73 (AD2), anti-CD127 (HCD127), anti-HLA-DR (L243), anti-CCR7 (G043H7) and Fluorochrome-conjugated anti-mouse mAbs: anti-CD3ε 
Statistical analysis
Results
Activation of conventional human T cells results in changes of CD73 and CD39 expression
The expression and function of CD39 and CD73 has been extensively analyzed on T reg cells 
Accumulation of CD39
+
HLA-DR + T cells in the joints of patients with juvenile arthritis
To assess the expression of these molecules in an inflammatory setting, we analyzed T cells from a site of chronic inflammation. Mononuclear cells were isolated from peripheral blood cells were detected in both PB and SF (Fig 3A and 3B ). Of note, the CD39 and CD73 expression profile of conventional T cells was similar in the peripheral blood of JIA patients and healthy controls (data not shown). population (S1 Fig). In the uninfected mouse, CD73 was expressed on a large subpopulation of CD4 + T cells and on the majority of CD8 + T cells (Fig 4) . (Fig 5A) . Expression of CD39 and CD73 was analyzed on IFN-γ + T cells (Fig 5B-5E ). Almost all IFN-γ + CD4 + and CD8 + T cells expressed CD39, while the majority of these cells were negative for CD73. For CD8 + T cells, this result could be confirmed on ex vivo stained OVA 257-264 -dextramer + CD8 + T cells, which exhibited higher levels of CD39 than dextramer-negative CD8 + T cells (Fig 5F) . CD73 showed an inverse expression profile with reduced expression on dextramer + CD8 + T cells and high expression on most of the dextramer-negative cells (Fig 5G) . The findings from the dextramer study corroborated results from the study depicted in Fig 5C and 5E and also argue against significant up-regulation of CD39 or down-regulation of CD73 during short-term in vitro peptide stimulation. In conclusion, our results indicate that, similar to our observations in humans, CD39 is upregulated and CD73 downregulated on CD4 + T H1 and CD8 + T effector cells generated in response to Lm infection.
Absence of CD39 enhances early control of L. monocytogenes infection
To test whether CD39 participates in the control of Lm, wildtype and CD39 -/-mice were infected with Lm and the bacterial burden in spleen was determined on day 2 post infection. Interestingly, CD39 -/-mice showed reduced bacterial titers 2 days post-infection (Fig 6A) ) from spleens of naive mice expressed CD39 but were negative for CD73. Surface expression of CD39 increased at day 3 of infection, the time point of maximal accumulation of these cells in Lm infected mice [40] , and then slowly declined to baseline levels (Figs 6B and S2). Inflammatory monocytes remained CD73 -during infection. Accumulation of neutrophils and inflammatory monocytes was determined in spleens of wildtype and CD39 -/-mice two days post-infection (S3A and S3B Fig) . Although, numbers of both cell populations were reduced in infected CD39 -/-mice, reduction did not reach a significant level.
The innate response to Lm is characterized by a substantial production of pro-inflammatory cytokines such as IL-1β, TNF-α and IL-6, which are important for the control of bacteria [41] . To examine whether the lack of CD39 influences the production of these cytokines, spleen cells from wildtype and CD39 -/-mice were cultured overnight with Lm, and TNF-α and IL-1β in supernatants were determined (Fig 6C and 6D) . Supernatants of wildtype and CD39 -/-spleen cells showed robust secretion of IL-1β and TNF-α. Interestingly, CD39 -/-spleen cells produced higher levels of IL-1β compared to wildtype spleen cells. For TNF-α, there was only a marginally higher production by CD39 -/-cells. Production of TNF-α was also determined by intracellular cytokine staining in inflammatory monocytes from spleens of mice infected for two days with Lm. We observed a trend towards enhanced TNF-α production in cells from CD39 -/-mice (Fig 
Absence of CD39 causes enhanced frequencies of listeria-specific CD8 + T cells
In the late phase of infection, control of Lm depends on T cells, particularly on CD8 + T cells.
Wildtype and CD39 -/-mice were infected with Lm and bacterial titers in spleens were determined on day 7 post infection. Bacterial titers in wildtype and CD39 -/-mice were at similarly low levels, indicating that control of Lm at this stage of response did not depend on CD39 ( Fig  7A) . To determine the magnitude of Lm-specific T-cell responses, wildtype and CD39 -/-mice were infected with LmOVA and CD8 + T cells from spleens of infected mice were analyzed for expression of OVA-specific TCRs using OVA 257-264 -dextramers on day 9 post infection. CD39 -/-mice had a higher frequency of dextramer + CD8 + T cells than wildtype controls ( Fig   7B) . These results demonstrate that absence of CD39 did not impair the formation of specific [3] , and result in augmented inflammasome activation and IL-1β secretion via P2X7 stimulation of these cells [50] [51] [52] . Deficiency of CD39 might further limit the production of immune suppressive adenosine by CD73. In line with these concepts, CD39 -/-and CD73 -/-mice present with enhanced local or systemic inflammation and increased levels of inflammatory cytokines in infection and inflammation models resulting in severe, even fatal immunopathology [24, 50, [53] [54] [55] [56] [57] [58] . Lack of CD73 has also been associated with improved control of Salmonella typhimurium and Helicobacter felis infection [24, 53, 56] . Similarly, enhanced inflammation with less restricted responses of inflammatory macrophages and granulocytes could lead to augmented early control of Lm in CD39 -/-mice.
Impairment of the CD39-CD73 axis might also explain the enhanced CD8 + T-cell response in Lm-infected CD39 -/-mice. Such a mechanism has been proposed for the aggravated disease observed in CD73 -/-mice in a graft versus host disease model [59] and enhanced anti-graft responses of CD73 -/-mice in transplantation models [60, 61] . On the other hand, CD73 -/-mice show unaltered CD8 + T-cell responses to infection with murine cytomegalovirus or recombinant adenovirus [45] , and CD39 -/-mice fail to respond in an allergic contact hypersensitivity model [55] . Thus, the function of the CD39-CD73 axis depends on the type of adaptive response. The CD39-CD73 axis might also affect CD8 + T cell effector functions, in addition to its impact on the frequencies, and thereby regulate the CD8 + T cell response. However, so far we have no evidence that the absence of CD39 causes alterations in cytokine production or cytotoxicity of CD8 + T cells in the Lm infection. Currently, it is unclear how CD39 attenuates CD8 + T-cell responses during Lm-infection. CD39 is expressed on listeria-reactive CD8 + T cells and therefore might directly interfere with the activation and function of these cells. Further, T reg cells could utilize CD39 to dampen the anti-listeria T-cell response. CD39 also contributes to the suppressive function of T r1 cells [62] , which likewise might interfere with the CD8 + T-cell response during Lm infection. Finally, we cannot exclude that CD39 expression on other cells in secondary lymphoid tissue or at sites of infection impairs CD8 + T-cell priming and function.
In conclusion, we demonstrate that in mouse and human, CD39 expression is not limited to T reg cells but a common feature of conventional CD4 + and CD8 + T cells activated in vitro and in vivo. In the Lm infection model, CD39 attenuates both innate and acquired responses. Although the precise mechanism of CD39-mediated suppression still needs to be delineated, our results underscore CD39 as an attractive target for modulating immune responses in autoimmunity and infection.
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